SEC Info - Phillips Barclay A - ‘3’ for 2/9/06 re: Acorda Therapeutics Inc.

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

PHILLIPS BARCLAY A

(Last)

(First)

(Middle)

C/O ACORDA THERAPEUTICS, INC.

15 SKYLINE DRIVE

(Street)

HAWTHORNE

10532

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
2/9/06

3. Issuer Name and Ticker or Trading Symbol
ACORDA THERAPEUTICS INC [ ACOR ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Series E-1 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	53,640 ⁽²⁾	13.806	I	See Footnotes ⁽³⁾
Series E-1 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	17,880 ⁽²⁾	13.806	I	See Footnotes ⁽⁴⁾
Series E-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	163,700 ⁽²⁾	13.806	I	See Footnotes ⁽³⁾
Series E-2 Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	54,566 ⁽²⁾	13.806	I	See Footnotes ⁽⁴⁾
Series H Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	24,453 ⁽²⁾	15.3348	I	See Footnotes ⁽³⁾
Series H Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	8,150 ⁽²⁾	15.3348	I	See Footnotes ⁽⁴⁾
Series I Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	67,945 ⁽²⁾	17.1132	I	See Footnotes ⁽³⁾
Series I Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	22,647 ⁽²⁾	17.1132	I	See Footnotes ⁽⁴⁾
Series J Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	98,116 ⁽²⁾	7.644	I	See Footnotes ⁽³⁾
Series J Convertible Preferred Stock	⁽¹⁾	⁽¹⁾	Common Stock	32,704 ⁽²⁾	7.644	I	See Footnotes ⁽⁴⁾

Explanation of Responses:

(1) The convertible preferred stock is convertible at any time, at the holder's discretion, and has no expiration date.

(2) The number of shares underlying convertible preferred stock in column 3 of Table II represents the number of shares of Common Stock of the Issuer that the convertible preferred stock will automatically convert into upon the closing of the Issuer's initial public offering.

(3) These shares are held by Vector Later-Stage Equity Fund II (QP), L.P. ("Vector QP"). According to information provided by Vector QP, Mr. Phillips could be deemed to have shared voting and dispositive power with respect to the shares of stock held by Vector QP. However, Mr. Phillips disclaims beneficial ownership except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed to be an admission that he is the beneficial owner of these securities for purposes of Section 16.

(4) These shares are held by Vector Later-Stage Equity Fund II, L.P. ("Vector"). According to information provided by Vector, Mr. Phillips could be deemed to have shared voting and dispositive power with respect to the shares of stock held by Vector. However, Mr. Phillips disclaims beneficial ownership except to the extent of his indirect pecuniary interest therein, and this report shall not be deemed to be an admission that he is the beneficial owner of these securities for purposes of Section 16.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

	/s/ Michelle Meyers, by power of attorney	2/9/06
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Phillips Barclay A – ‘3’ for 2/9/06 re: Acorda Therapeutics Inc.

On: Thursday, 2/9/06, at 4:24pm ET · For: 2/9/06 · As: Director · Accession #: 1104659-6-7400 · File #: 0-50513

Previous ‘3’: ‘3’ on / for 10/29/03 · Next: ‘3’ on 7/3/13 for 6/24/13 · Latest: ‘3’ on 11/19/19 for 11/18/19

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents

‘3’ — Initial Statement of Beneficial Ownership of Securities by an Insider — a3.xml/2.2